nodes	percent_of_prediction	percent_of_DWPC	metapath
Alitretinoin—ABCB1—ulcerative colitis	0.337	1	CbGaD
Alitretinoin—CYP1A2—Nicotine—ulcerative colitis	0.0254	0.223	CbGbCtD
Alitretinoin—ABCB1—Methylprednisolone—ulcerative colitis	0.0228	0.2	CbGbCtD
Alitretinoin—ABCB1—Betamethasone—ulcerative colitis	0.0148	0.13	CbGbCtD
Alitretinoin—ABCB1—Prednisolone—ulcerative colitis	0.0146	0.128	CbGbCtD
Alitretinoin—ABCB1—Hydrocortisone—ulcerative colitis	0.0138	0.122	CbGbCtD
Alitretinoin—ABCB1—Prednisone—ulcerative colitis	0.0138	0.121	CbGbCtD
Alitretinoin—ABCB1—Dexamethasone—ulcerative colitis	0.00861	0.0757	CbGbCtD
Alitretinoin—RXRG—Gene Expression—ZFP90—ulcerative colitis	0.000408	0.00201	CbGpPWpGaD
Alitretinoin—RARB—Gene Expression—ZFP90—ulcerative colitis	0.0004	0.00197	CbGpPWpGaD
Alitretinoin—RXRA—Phase 1 - Functionalization of compounds—PTGS1—ulcerative colitis	0.000391	0.00193	CbGpPWpGaD
Alitretinoin—RXRG—Generic Transcription Pathway—NR5A2—ulcerative colitis	0.000389	0.00192	CbGpPWpGaD
Alitretinoin—RXRA—Nuclear Receptor transcription pathway—VDR—ulcerative colitis	0.000384	0.00189	CbGpPWpGaD
Alitretinoin—RXRB—Gene Expression—ZFP90—ulcerative colitis	0.000384	0.00189	CbGpPWpGaD
Alitretinoin—RARA—Gene Expression—ZFP90—ulcerative colitis	0.000384	0.00189	CbGpPWpGaD
Alitretinoin—RARB—Generic Transcription Pathway—NR5A2—ulcerative colitis	0.000382	0.00188	CbGpPWpGaD
Alitretinoin—ABCB1—Drug Induction of Bile Acid Pathway—VDR—ulcerative colitis	0.00037	0.00182	CbGpPWpGaD
Alitretinoin—RXRB—Generic Transcription Pathway—NR5A2—ulcerative colitis	0.000366	0.0018	CbGpPWpGaD
Alitretinoin—RARA—Generic Transcription Pathway—NR5A2—ulcerative colitis	0.000366	0.0018	CbGpPWpGaD
Alitretinoin—RXRA—Nuclear Receptors—PPARG—ulcerative colitis	0.000339	0.00167	CbGpPWpGaD
Alitretinoin—CRABP1—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—ulcerative colitis	0.000323	0.00159	CbGpPWpGaD
Alitretinoin—CRABP2—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—ulcerative colitis	0.000323	0.00159	CbGpPWpGaD
Alitretinoin—RXRA—Bile acid and bile salt metabolism—ALB—ulcerative colitis	0.000318	0.00157	CbGpPWpGaD
Alitretinoin—RXRA—a6b1 and a6b4 Integrin signaling—CDH1—ulcerative colitis	0.000282	0.00139	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—CHP1—ulcerative colitis	0.000281	0.00139	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism—CHP1—ulcerative colitis	0.000281	0.00139	CbGpPWpGaD
Alitretinoin—RXRA—Transcription factor regulation in adipogenesis—TNF—ulcerative colitis	0.000279	0.00137	CbGpPWpGaD
Alitretinoin—RARB—Integrated Pancreatic Cancer Pathway—ABCB1—ulcerative colitis	0.000268	0.00132	CbGpPWpGaD
Alitretinoin—RXRA—Nuclear Receptor transcription pathway—PPARG—ulcerative colitis	0.000268	0.00132	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism of lipids and lipoproteins—PTGS1—ulcerative colitis	0.000264	0.0013	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism of lipids and lipoproteins—PTGS1—ulcerative colitis	0.000264	0.0013	CbGpPWpGaD
Alitretinoin—RXRA—RXR and RAR heterodimerization with other nuclear receptor—TGFB1—ulcerative colitis	0.000261	0.00129	CbGpPWpGaD
Alitretinoin—RXRG—Adipogenesis—PPARG—ulcerative colitis	0.000259	0.00127	CbGpPWpGaD
Alitretinoin—RARA—Integrated Pancreatic Cancer Pathway—ABCB1—ulcerative colitis	0.000257	0.00126	CbGpPWpGaD
Alitretinoin—RXRA—Transmembrane transport of small molecules—SLC26A3—ulcerative colitis	0.000252	0.00124	CbGpPWpGaD
Alitretinoin—RXRA—RXR and RAR heterodimerization with other nuclear receptor—TNF—ulcerative colitis	0.000244	0.0012	CbGpPWpGaD
Alitretinoin—RARA—Adipogenesis—PPARG—ulcerative colitis	0.000243	0.0012	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—DLD—ulcerative colitis	0.000243	0.0012	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism—DLD—ulcerative colitis	0.000243	0.0012	CbGpPWpGaD
Alitretinoin—RARG—Generic Transcription Pathway—HNF4A—ulcerative colitis	0.000238	0.00117	CbGpPWpGaD
Alitretinoin—RARG—Generic Transcription Pathway—MAML2—ulcerative colitis	0.000232	0.00114	CbGpPWpGaD
Alitretinoin—RXRA—Transcription factor regulation in adipogenesis—IL6—ulcerative colitis	0.000225	0.00111	CbGpPWpGaD
Alitretinoin—RXRG—Generic Transcription Pathway—HNF4A—ulcerative colitis	0.000217	0.00107	CbGpPWpGaD
Alitretinoin—RXRA—Organelle biogenesis and maintenance—CALM3—ulcerative colitis	0.000215	0.00106	CbGpPWpGaD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—HNF4A—ulcerative colitis	0.000214	0.00106	CbGpPWpGaD
Alitretinoin—RARB—Generic Transcription Pathway—HNF4A—ulcerative colitis	0.000213	0.00105	CbGpPWpGaD
Alitretinoin—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—ulcerative colitis	0.000212	0.00105	CbGpPWpGaD
Alitretinoin—RXRG—Generic Transcription Pathway—MAML2—ulcerative colitis	0.000212	0.00104	CbGpPWpGaD
Alitretinoin—RXRA—Biological oxidations—PTGS1—ulcerative colitis	0.000208	0.00102	CbGpPWpGaD
Alitretinoin—RARB—Generic Transcription Pathway—MAML2—ulcerative colitis	0.000208	0.00102	CbGpPWpGaD
Alitretinoin—RARG—Gene Expression—NR5A2—ulcerative colitis	0.000205	0.00101	CbGpPWpGaD
Alitretinoin—RXRB—Generic Transcription Pathway—HNF4A—ulcerative colitis	0.000204	0.00101	CbGpPWpGaD
Alitretinoin—RARA—Generic Transcription Pathway—HNF4A—ulcerative colitis	0.000204	0.00101	CbGpPWpGaD
Alitretinoin—ABCB1—HIF-1-alpha transcription factor network—HNF4A—ulcerative colitis	0.000201	0.000987	CbGpPWpGaD
Alitretinoin—RXRA—Gene Expression—ZFP90—ulcerative colitis	0.0002	0.000984	CbGpPWpGaD
Alitretinoin—RARA—Generic Transcription Pathway—MAML2—ulcerative colitis	0.000199	0.000981	CbGpPWpGaD
Alitretinoin—RXRB—Generic Transcription Pathway—MAML2—ulcerative colitis	0.000199	0.000981	CbGpPWpGaD
Alitretinoin—RXRA—Transcriptional regulation of white adipocyte differentiation—PPARG—ulcerative colitis	0.000193	0.000948	CbGpPWpGaD
Alitretinoin—RXRA—Generic Transcription Pathway—NR5A2—ulcerative colitis	0.000191	0.000939	CbGpPWpGaD
Alitretinoin—RXRG—Gene Expression—NR5A2—ulcerative colitis	0.000187	0.000922	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—ARPC2—ulcerative colitis	0.000185	0.00091	CbGpPWpGaD
Alitretinoin—RARB—Gene Expression—NR5A2—ulcerative colitis	0.000184	0.000905	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—NR5A2—ulcerative colitis	0.000179	0.000884	CbGpPWpGaD
Alitretinoin—CYP1A2—Arachidonic acid metabolism—PTGS1—ulcerative colitis	0.000178	0.000877	CbGpPWpGaD
Alitretinoin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12B—ulcerative colitis	0.000177	0.000872	CbGpPWpGaD
Alitretinoin—RXRB—Gene Expression—NR5A2—ulcerative colitis	0.000176	0.000867	CbGpPWpGaD
Alitretinoin—RARA—Gene Expression—NR5A2—ulcerative colitis	0.000176	0.000867	CbGpPWpGaD
Alitretinoin—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—ulcerative colitis	0.00017	0.000836	CbGpPWpGaD
Alitretinoin—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—ulcerative colitis	0.00017	0.000835	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—MST1—ulcerative colitis	0.000163	0.000803	CbGpPWpGaD
Alitretinoin—RXRG—Adipogenesis—STAT3—ulcerative colitis	0.000159	0.000781	CbGpPWpGaD
Alitretinoin—CYP1A2—Estrogen Receptor Pathway—STAT3—ulcerative colitis	0.000156	0.00077	CbGpPWpGaD
Alitretinoin—RXRA—Transcriptional regulation of white adipocyte differentiation—RELA—ulcerative colitis	0.000156	0.000768	CbGpPWpGaD
Alitretinoin—ABCB1—Allograft Rejection—IL17A—ulcerative colitis	0.000155	0.000762	CbGpPWpGaD
Alitretinoin—RARA—Adipogenesis—STAT3—ulcerative colitis	0.000149	0.000734	CbGpPWpGaD
Alitretinoin—RXRA—Transmembrane transport of small molecules—SLC22A5—ulcerative colitis	0.000148	0.00073	CbGpPWpGaD
Alitretinoin—RXRA—Transmembrane transport of small molecules—SLC22A4—ulcerative colitis	0.000148	0.00073	CbGpPWpGaD
Alitretinoin—RARG—Generic Transcription Pathway—VDR—ulcerative colitis	0.000148	0.000729	CbGpPWpGaD
Alitretinoin—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—ulcerative colitis	0.000148	0.000729	CbGpPWpGaD
Alitretinoin—RXRG—Adipogenesis—TGFB1—ulcerative colitis	0.000147	0.000724	CbGpPWpGaD
Alitretinoin—RARB—Integrated Pancreatic Cancer Pathway—PTGS2—ulcerative colitis	0.000147	0.000722	CbGpPWpGaD
Alitretinoin—RXRA—PPARA activates gene expression—PPARG—ulcerative colitis	0.000145	0.000713	CbGpPWpGaD
Alitretinoin—ABCB1—Allograft Rejection—IL12B—ulcerative colitis	0.000144	0.000709	CbGpPWpGaD
Alitretinoin—RXRA—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARG—ulcerative colitis	0.000142	0.000698	CbGpPWpGaD
Alitretinoin—RARA—Integrated Pancreatic Cancer Pathway—PTGS2—ulcerative colitis	0.000141	0.000692	CbGpPWpGaD
Alitretinoin—RARA—Adipogenesis—TGFB1—ulcerative colitis	0.000138	0.000681	CbGpPWpGaD
Alitretinoin—RXRG—Adipogenesis—TNF—ulcerative colitis	0.000137	0.000676	CbGpPWpGaD
Alitretinoin—RXRG—Generic Transcription Pathway—VDR—ulcerative colitis	0.000135	0.000667	CbGpPWpGaD
Alitretinoin—ABCB1—Allograft Rejection—CTLA4—ulcerative colitis	0.000135	0.000666	CbGpPWpGaD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—ABCB1—ulcerative colitis	0.000134	0.000659	CbGpPWpGaD
Alitretinoin—RARB—Generic Transcription Pathway—VDR—ulcerative colitis	0.000133	0.000654	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—LAMB1—ulcerative colitis	0.000132	0.000651	CbGpPWpGaD
Alitretinoin—RXRA—Transcriptional regulation of white adipocyte differentiation—NFKB1—ulcerative colitis	0.000132	0.000647	CbGpPWpGaD
Alitretinoin—RARA—Adipogenesis—TNF—ulcerative colitis	0.000129	0.000636	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	0.000128	0.000632	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	0.000128	0.000632	CbGpPWpGaD
Alitretinoin—RARA—Generic Transcription Pathway—VDR—ulcerative colitis	0.000127	0.000627	CbGpPWpGaD
Alitretinoin—RXRB—Generic Transcription Pathway—VDR—ulcerative colitis	0.000127	0.000627	CbGpPWpGaD
Alitretinoin—RARB—Integrated Pancreatic Cancer Pathway—NFKB1—ulcerative colitis	0.000127	0.000626	CbGpPWpGaD
Alitretinoin—RXRA—Adipogenesis—PPARG—ulcerative colitis	0.000127	0.000624	CbGpPWpGaD
Alitretinoin—CYP1A2—Phase 1 - Functionalization of compounds—PTGS1—ulcerative colitis	0.000125	0.000615	CbGpPWpGaD
Alitretinoin—RARA—Integrated Pancreatic Cancer Pathway—NFKB1—ulcerative colitis	0.000122	0.000601	CbGpPWpGaD
Alitretinoin—ABCB1—Allograft Rejection—HLA-DQA1—ulcerative colitis	0.000119	0.000586	CbGpPWpGaD
Alitretinoin—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—ulcerative colitis	0.000118	0.000582	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism—PTGS1—ulcerative colitis	0.000117	0.000578	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—PTGS1—ulcerative colitis	0.000117	0.000578	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—TCF4—ulcerative colitis	0.000116	0.000569	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	0.000116	0.000569	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	0.000116	0.000569	CbGpPWpGaD
Alitretinoin—RARG—Gene Expression—HNF4A—ulcerative colitis	0.000114	0.000563	CbGpPWpGaD
Alitretinoin—RARG—Gene Expression—MAML2—ulcerative colitis	0.000112	0.000549	CbGpPWpGaD
Alitretinoin—RXRG—Adipogenesis—IL6—ulcerative colitis	0.000111	0.000546	CbGpPWpGaD
Alitretinoin—RXRA—Transcriptional regulation of white adipocyte differentiation—TGFB1—ulcerative colitis	0.00011	0.000539	CbGpPWpGaD
Alitretinoin—RXRA—Generic Transcription Pathway—HNF4A—ulcerative colitis	0.000107	0.000525	CbGpPWpGaD
Alitretinoin—RARB—Integrated Pancreatic Cancer Pathway—TGFB1—ulcerative colitis	0.000106	0.000522	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism—CALM3—ulcerative colitis	0.000106	0.000521	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—CALM3—ulcerative colitis	0.000106	0.000521	CbGpPWpGaD
Alitretinoin—ABCB1—Allograft Rejection—IL10—ulcerative colitis	0.000105	0.000518	CbGpPWpGaD
Alitretinoin—RXRG—Gene Expression—HNF4A—ulcerative colitis	0.000105	0.000515	CbGpPWpGaD
Alitretinoin—RARA—Adipogenesis—IL6—ulcerative colitis	0.000104	0.000513	CbGpPWpGaD
Alitretinoin—RXRA—Generic Transcription Pathway—MAML2—ulcerative colitis	0.000104	0.000511	CbGpPWpGaD
Alitretinoin—RARG—Generic Transcription Pathway—PPARG—ulcerative colitis	0.000103	0.000508	CbGpPWpGaD
Alitretinoin—RARB—Gene Expression—HNF4A—ulcerative colitis	0.000103	0.000505	CbGpPWpGaD
Alitretinoin—RXRA—Transcriptional regulation of white adipocyte differentiation—TNF—ulcerative colitis	0.000102	0.000504	CbGpPWpGaD
Alitretinoin—RXRG—Gene Expression—MAML2—ulcerative colitis	0.000102	0.000502	CbGpPWpGaD
Alitretinoin—RARA—Integrated Pancreatic Cancer Pathway—TGFB1—ulcerative colitis	0.000102	0.0005	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	0.000101	0.000497	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	0.000101	0.000497	CbGpPWpGaD
Alitretinoin—ABCB1—Transmembrane transport of small molecules—SLC26A3—ulcerative colitis	0.000101	0.000495	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—HNF4A—ulcerative colitis	0.0001	0.000494	CbGpPWpGaD
Alitretinoin—RARB—Gene Expression—MAML2—ulcerative colitis	0.0001	0.000493	CbGpPWpGaD
Alitretinoin—RARB—Integrated Pancreatic Cancer Pathway—TNF—ulcerative colitis	9.9e-05	0.000487	CbGpPWpGaD
Alitretinoin—RXRB—Gene Expression—HNF4A—ulcerative colitis	9.84e-05	0.000485	CbGpPWpGaD
Alitretinoin—RARA—Gene Expression—HNF4A—ulcerative colitis	9.84e-05	0.000485	CbGpPWpGaD
Alitretinoin—RXRA—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—ulcerative colitis	9.77e-05	0.000481	CbGpPWpGaD
Alitretinoin—RXRB—Gene Expression—MAML2—ulcerative colitis	9.59e-05	0.000472	CbGpPWpGaD
Alitretinoin—RARA—Gene Expression—MAML2—ulcerative colitis	9.59e-05	0.000472	CbGpPWpGaD
Alitretinoin—RARA—Integrated Pancreatic Cancer Pathway—TNF—ulcerative colitis	9.49e-05	0.000467	CbGpPWpGaD
Alitretinoin—RXRG—Generic Transcription Pathway—PPARG—ulcerative colitis	9.44e-05	0.000465	CbGpPWpGaD
Alitretinoin—RARB—Generic Transcription Pathway—PPARG—ulcerative colitis	9.26e-05	0.000456	CbGpPWpGaD
Alitretinoin—RXRA—Transmembrane transport of small molecules—SLC11A1—ulcerative colitis	9.23e-05	0.000455	CbGpPWpGaD
Alitretinoin—RXRA—Gene Expression—NR5A2—ulcerative colitis	9.18e-05	0.000452	CbGpPWpGaD
Alitretinoin—CYP1A2—Melatonin metabolism and effects—NFKB1—ulcerative colitis	9.16e-05	0.000451	CbGpPWpGaD
Alitretinoin—RARA—Generic Transcription Pathway—PPARG—ulcerative colitis	8.88e-05	0.000437	CbGpPWpGaD
Alitretinoin—RXRB—Generic Transcription Pathway—PPARG—ulcerative colitis	8.88e-05	0.000437	CbGpPWpGaD
Alitretinoin—RARB—Integrated Pancreatic Cancer Pathway—TP53—ulcerative colitis	8.73e-05	0.00043	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—HNF4A—ulcerative colitis	8.57e-05	0.000422	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—CHP1—ulcerative colitis	8.52e-05	0.000419	CbGpPWpGaD
Alitretinoin—ABCB1—Allograft Rejection—HLA-DRB1—ulcerative colitis	8.47e-05	0.000417	CbGpPWpGaD
Alitretinoin—Hyperhidrosis—Prednisolone—ulcerative colitis	8.37e-05	0.000242	CcSEcCtD
Alitretinoin—RARA—Integrated Pancreatic Cancer Pathway—TP53—ulcerative colitis	8.37e-05	0.000412	CbGpPWpGaD
Alitretinoin—Shock—Hydrocortisone—ulcerative colitis	8.32e-05	0.000241	CcSEcCtD
Alitretinoin—Myalgia—Triamcinolone—ulcerative colitis	8.31e-05	0.00024	CcSEcCtD
Alitretinoin—Vomiting—Azathioprine—ulcerative colitis	8.3e-05	0.00024	CcSEcCtD
Alitretinoin—Nervous system disorder—Hydrocortisone—ulcerative colitis	8.29e-05	0.00024	CcSEcCtD
Alitretinoin—Myalgia—Methylprednisolone—ulcerative colitis	8.29e-05	0.00024	CcSEcCtD
Alitretinoin—Arthralgia—Methylprednisolone—ulcerative colitis	8.29e-05	0.00024	CcSEcCtD
Alitretinoin—Eye disorder—Prednisone—ulcerative colitis	8.28e-05	0.000239	CcSEcCtD
Alitretinoin—Anxiety—Methylprednisolone—ulcerative colitis	8.26e-05	0.000239	CcSEcCtD
Alitretinoin—Tachycardia—Hydrocortisone—ulcerative colitis	8.25e-05	0.000239	CcSEcCtD
Alitretinoin—Rash—Azathioprine—ulcerative colitis	8.23e-05	0.000238	CcSEcCtD
Alitretinoin—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ulcerative colitis	8.23e-05	0.000238	CcSEcCtD
Alitretinoin—Dermatitis—Azathioprine—ulcerative colitis	8.22e-05	0.000238	CcSEcCtD
Alitretinoin—CRABP2—Metabolism—ABCB1—ulcerative colitis	8.22e-05	0.000405	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—ABCB1—ulcerative colitis	8.22e-05	0.000405	CbGpPWpGaD
Alitretinoin—Flushing—Prednisone—ulcerative colitis	8.22e-05	0.000238	CcSEcCtD
Alitretinoin—Skin disorder—Hydrocortisone—ulcerative colitis	8.21e-05	0.000238	CcSEcCtD
Alitretinoin—Ill-defined disorder—Dexamethasone—ulcerative colitis	8.21e-05	0.000238	CcSEcCtD
Alitretinoin—Ill-defined disorder—Betamethasone—ulcerative colitis	8.21e-05	0.000238	CcSEcCtD
Alitretinoin—Discomfort—Triamcinolone—ulcerative colitis	8.21e-05	0.000237	CcSEcCtD
Alitretinoin—Discomfort—Methylprednisolone—ulcerative colitis	8.19e-05	0.000237	CcSEcCtD
Alitretinoin—Headache—Azathioprine—ulcerative colitis	8.18e-05	0.000237	CcSEcCtD
Alitretinoin—Hyperhidrosis—Hydrocortisone—ulcerative colitis	8.17e-05	0.000236	CcSEcCtD
Alitretinoin—Diarrhoea—Mesalazine—ulcerative colitis	8.14e-05	0.000235	CcSEcCtD
Alitretinoin—Dry mouth—Triamcinolone—ulcerative colitis	8.12e-05	0.000235	CcSEcCtD
Alitretinoin—Anorexia—Hydrocortisone—ulcerative colitis	8.06e-05	0.000233	CcSEcCtD
Alitretinoin—Angiopathy—Prednisone—ulcerative colitis	8.03e-05	0.000232	CcSEcCtD
Alitretinoin—Confusional state—Methylprednisolone—ulcerative colitis	8.01e-05	0.000232	CcSEcCtD
Alitretinoin—RXRA—Metabolism of lipids and lipoproteins—PTGS1—ulcerative colitis	7.98e-05	0.000393	CbGpPWpGaD
Alitretinoin—Malaise—Betamethasone—ulcerative colitis	7.98e-05	0.000231	CcSEcCtD
Alitretinoin—Malaise—Dexamethasone—ulcerative colitis	7.98e-05	0.000231	CcSEcCtD
Alitretinoin—Anaphylactic shock—Triamcinolone—ulcerative colitis	7.96e-05	0.00023	CcSEcCtD
Alitretinoin—Oedema—Triamcinolone—ulcerative colitis	7.96e-05	0.00023	CcSEcCtD
Alitretinoin—Anaphylactic shock—Methylprednisolone—ulcerative colitis	7.94e-05	0.00023	CcSEcCtD
Alitretinoin—Syncope—Betamethasone—ulcerative colitis	7.94e-05	0.00023	CcSEcCtD
Alitretinoin—Syncope—Dexamethasone—ulcerative colitis	7.94e-05	0.00023	CcSEcCtD
Alitretinoin—Arrhythmia—Prednisone—ulcerative colitis	7.91e-05	0.000229	CcSEcCtD
Alitretinoin—Infection—Triamcinolone—ulcerative colitis	7.91e-05	0.000229	CcSEcCtD
Alitretinoin—Hypotension—Hydrocortisone—ulcerative colitis	7.9e-05	0.000229	CcSEcCtD
Alitretinoin—Infection—Methylprednisolone—ulcerative colitis	7.89e-05	0.000228	CcSEcCtD
Alitretinoin—Dizziness—Mesalazine—ulcerative colitis	7.86e-05	0.000227	CcSEcCtD
Alitretinoin—Shock—Triamcinolone—ulcerative colitis	7.83e-05	0.000227	CcSEcCtD
Alitretinoin—Insomnia—Prednisolone—ulcerative colitis	7.83e-05	0.000227	CcSEcCtD
Alitretinoin—Alopecia—Prednisone—ulcerative colitis	7.83e-05	0.000226	CcSEcCtD
Alitretinoin—Shock—Methylprednisolone—ulcerative colitis	7.82e-05	0.000226	CcSEcCtD
Alitretinoin—Nervous system disorder—Methylprednisolone—ulcerative colitis	7.79e-05	0.000225	CcSEcCtD
Alitretinoin—Loss of consciousness—Dexamethasone—ulcerative colitis	7.78e-05	0.000225	CcSEcCtD
Alitretinoin—Loss of consciousness—Betamethasone—ulcerative colitis	7.78e-05	0.000225	CcSEcCtD
Alitretinoin—Paraesthesia—Prednisolone—ulcerative colitis	7.77e-05	0.000225	CcSEcCtD
Alitretinoin—RXRA—Adipogenesis—STAT3—ulcerative colitis	7.77e-05	0.000383	CbGpPWpGaD
Alitretinoin—Tachycardia—Triamcinolone—ulcerative colitis	7.77e-05	0.000225	CcSEcCtD
Alitretinoin—Mental disorder—Prednisone—ulcerative colitis	7.76e-05	0.000224	CcSEcCtD
Alitretinoin—Nausea—Azathioprine—ulcerative colitis	7.75e-05	0.000224	CcSEcCtD
Alitretinoin—Tachycardia—Methylprednisolone—ulcerative colitis	7.75e-05	0.000224	CcSEcCtD
Alitretinoin—Skin disorder—Methylprednisolone—ulcerative colitis	7.72e-05	0.000223	CcSEcCtD
Alitretinoin—Erythema—Prednisone—ulcerative colitis	7.71e-05	0.000223	CcSEcCtD
Alitretinoin—Malnutrition—Prednisone—ulcerative colitis	7.71e-05	0.000223	CcSEcCtD
Alitretinoin—Musculoskeletal discomfort—Hydrocortisone—ulcerative colitis	7.7e-05	0.000223	CcSEcCtD
Alitretinoin—Hyperhidrosis—Triamcinolone—ulcerative colitis	7.7e-05	0.000223	CcSEcCtD
Alitretinoin—Hyperhidrosis—Methylprednisolone—ulcerative colitis	7.68e-05	0.000222	CcSEcCtD
Alitretinoin—CRABP1—Metabolism—ADCY5—ulcerative colitis	7.67e-05	0.000378	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism—ADCY5—ulcerative colitis	7.67e-05	0.000378	CbGpPWpGaD
Alitretinoin—Convulsion—Dexamethasone—ulcerative colitis	7.67e-05	0.000222	CcSEcCtD
Alitretinoin—Convulsion—Betamethasone—ulcerative colitis	7.67e-05	0.000222	CcSEcCtD
Alitretinoin—Insomnia—Hydrocortisone—ulcerative colitis	7.65e-05	0.000221	CcSEcCtD
Alitretinoin—Hypertension—Betamethasone—ulcerative colitis	7.64e-05	0.000221	CcSEcCtD
Alitretinoin—Hypertension—Dexamethasone—ulcerative colitis	7.64e-05	0.000221	CcSEcCtD
Alitretinoin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—ulcerative colitis	7.61e-05	0.000375	CbGpPWpGaD
Alitretinoin—Paraesthesia—Hydrocortisone—ulcerative colitis	7.59e-05	0.00022	CcSEcCtD
Alitretinoin—Vomiting—Mesalazine—ulcerative colitis	7.56e-05	0.000219	CcSEcCtD
Alitretinoin—Myalgia—Betamethasone—ulcerative colitis	7.54e-05	0.000218	CcSEcCtD
Alitretinoin—Myalgia—Dexamethasone—ulcerative colitis	7.54e-05	0.000218	CcSEcCtD
Alitretinoin—CYP1A2—Aryl Hydrocarbon Receptor—RELA—ulcerative colitis	7.51e-05	0.00037	CbGpPWpGaD
Alitretinoin—Anxiety—Betamethasone—ulcerative colitis	7.51e-05	0.000217	CcSEcCtD
Alitretinoin—Anxiety—Dexamethasone—ulcerative colitis	7.51e-05	0.000217	CcSEcCtD
Alitretinoin—Rash—Mesalazine—ulcerative colitis	7.5e-05	0.000217	CcSEcCtD
Alitretinoin—Dermatitis—Mesalazine—ulcerative colitis	7.49e-05	0.000217	CcSEcCtD
Alitretinoin—Headache—Mesalazine—ulcerative colitis	7.45e-05	0.000216	CcSEcCtD
Alitretinoin—Discomfort—Betamethasone—ulcerative colitis	7.45e-05	0.000215	CcSEcCtD
Alitretinoin—Discomfort—Dexamethasone—ulcerative colitis	7.45e-05	0.000215	CcSEcCtD
Alitretinoin—Dyspepsia—Hydrocortisone—ulcerative colitis	7.44e-05	0.000215	CcSEcCtD
Alitretinoin—Hypotension—Methylprednisolone—ulcerative colitis	7.42e-05	0.000215	CcSEcCtD
Alitretinoin—Pain—Prednisolone—ulcerative colitis	7.4e-05	0.000214	CcSEcCtD
Alitretinoin—RXRA—Metabolism—DLD—ulcerative colitis	7.35e-05	0.000362	CbGpPWpGaD
Alitretinoin—Decreased appetite—Hydrocortisone—ulcerative colitis	7.35e-05	0.000213	CcSEcCtD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—PTGS2—ulcerative colitis	7.33e-05	0.000361	CbGpPWpGaD
Alitretinoin—Gastrointestinal disorder—Hydrocortisone—ulcerative colitis	7.3e-05	0.000211	CcSEcCtD
Alitretinoin—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—ulcerative colitis	7.3e-05	0.000359	CbGpPWpGaD
Alitretinoin—Fatigue—Hydrocortisone—ulcerative colitis	7.29e-05	0.000211	CcSEcCtD
Alitretinoin—Vision blurred—Prednisone—ulcerative colitis	7.27e-05	0.00021	CcSEcCtD
Alitretinoin—Musculoskeletal discomfort—Triamcinolone—ulcerative colitis	7.25e-05	0.00021	CcSEcCtD
Alitretinoin—Musculoskeletal discomfort—Methylprednisolone—ulcerative colitis	7.24e-05	0.000209	CcSEcCtD
Alitretinoin—Pain—Hydrocortisone—ulcerative colitis	7.23e-05	0.000209	CcSEcCtD
Alitretinoin—Anaphylactic shock—Betamethasone—ulcerative colitis	7.22e-05	0.000209	CcSEcCtD
Alitretinoin—Oedema—Betamethasone—ulcerative colitis	7.22e-05	0.000209	CcSEcCtD
Alitretinoin—Anaphylactic shock—Dexamethasone—ulcerative colitis	7.22e-05	0.000209	CcSEcCtD
Alitretinoin—Oedema—Dexamethasone—ulcerative colitis	7.22e-05	0.000209	CcSEcCtD
Alitretinoin—RXRA—Adipogenesis—TGFB1—ulcerative colitis	7.21e-05	0.000355	CbGpPWpGaD
Alitretinoin—Insomnia—Triamcinolone—ulcerative colitis	7.2e-05	0.000208	CcSEcCtD
Alitretinoin—Insomnia—Methylprednisolone—ulcerative colitis	7.19e-05	0.000208	CcSEcCtD
Alitretinoin—Infection—Betamethasone—ulcerative colitis	7.18e-05	0.000208	CcSEcCtD
Alitretinoin—Infection—Dexamethasone—ulcerative colitis	7.18e-05	0.000208	CcSEcCtD
Alitretinoin—Ill-defined disorder—Prednisone—ulcerative colitis	7.15e-05	0.000207	CcSEcCtD
Alitretinoin—Paraesthesia—Triamcinolone—ulcerative colitis	7.15e-05	0.000207	CcSEcCtD
Alitretinoin—Feeling abnormal—Prednisolone—ulcerative colitis	7.13e-05	0.000206	CcSEcCtD
Alitretinoin—Paraesthesia—Methylprednisolone—ulcerative colitis	7.13e-05	0.000206	CcSEcCtD
Alitretinoin—RARG—Gene Expression—VDR—ulcerative colitis	7.13e-05	0.000351	CbGpPWpGaD
Alitretinoin—Anaemia—Prednisone—ulcerative colitis	7.13e-05	0.000206	CcSEcCtD
Alitretinoin—Shock—Dexamethasone—ulcerative colitis	7.11e-05	0.000206	CcSEcCtD
Alitretinoin—Shock—Betamethasone—ulcerative colitis	7.11e-05	0.000206	CcSEcCtD
Alitretinoin—Dyspnoea—Triamcinolone—ulcerative colitis	7.1e-05	0.000205	CcSEcCtD
Alitretinoin—Nervous system disorder—Dexamethasone—ulcerative colitis	7.08e-05	0.000205	CcSEcCtD
Alitretinoin—Nervous system disorder—Betamethasone—ulcerative colitis	7.08e-05	0.000205	CcSEcCtD
Alitretinoin—Agitation—Prednisone—ulcerative colitis	7.08e-05	0.000205	CcSEcCtD
Alitretinoin—Thrombocytopenia—Dexamethasone—ulcerative colitis	7.07e-05	0.000205	CcSEcCtD
Alitretinoin—Thrombocytopenia—Betamethasone—ulcerative colitis	7.07e-05	0.000205	CcSEcCtD
Alitretinoin—Nausea—Mesalazine—ulcerative colitis	7.06e-05	0.000204	CcSEcCtD
Alitretinoin—Tachycardia—Dexamethasone—ulcerative colitis	7.05e-05	0.000204	CcSEcCtD
Alitretinoin—Tachycardia—Betamethasone—ulcerative colitis	7.05e-05	0.000204	CcSEcCtD
Alitretinoin—Dyspepsia—Triamcinolone—ulcerative colitis	7.01e-05	0.000203	CcSEcCtD
Alitretinoin—Dyspepsia—Methylprednisolone—ulcerative colitis	6.99e-05	0.000202	CcSEcCtD
Alitretinoin—Hyperhidrosis—Betamethasone—ulcerative colitis	6.98e-05	0.000202	CcSEcCtD
Alitretinoin—Hyperhidrosis—Dexamethasone—ulcerative colitis	6.98e-05	0.000202	CcSEcCtD
Alitretinoin—Feeling abnormal—Hydrocortisone—ulcerative colitis	6.97e-05	0.000202	CcSEcCtD
Alitretinoin—Malaise—Prednisone—ulcerative colitis	6.95e-05	0.000201	CcSEcCtD
Alitretinoin—Gastrointestinal pain—Hydrocortisone—ulcerative colitis	6.91e-05	0.0002	CcSEcCtD
Alitretinoin—Syncope—Prednisone—ulcerative colitis	6.91e-05	0.0002	CcSEcCtD
Alitretinoin—Anorexia—Dexamethasone—ulcerative colitis	6.89e-05	0.000199	CcSEcCtD
Alitretinoin—Anorexia—Betamethasone—ulcerative colitis	6.89e-05	0.000199	CcSEcCtD
Alitretinoin—Urticaria—Prednisolone—ulcerative colitis	6.88e-05	0.000199	CcSEcCtD
Alitretinoin—Fatigue—Triamcinolone—ulcerative colitis	6.86e-05	0.000199	CcSEcCtD
Alitretinoin—Fatigue—Methylprednisolone—ulcerative colitis	6.85e-05	0.000198	CcSEcCtD
Alitretinoin—CYP1A2—Arachidonic acid metabolism—PTGS2—ulcerative colitis	6.83e-05	0.000336	CbGpPWpGaD
Alitretinoin—Pain—Triamcinolone—ulcerative colitis	6.81e-05	0.000197	CcSEcCtD
Alitretinoin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—ulcerative colitis	6.79e-05	0.000334	CbGpPWpGaD
Alitretinoin—Loss of consciousness—Prednisone—ulcerative colitis	6.78e-05	0.000196	CcSEcCtD
Alitretinoin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—ulcerative colitis	6.77e-05	0.000333	CbGpPWpGaD
Alitretinoin—Hypotension—Dexamethasone—ulcerative colitis	6.75e-05	0.000195	CcSEcCtD
Alitretinoin—Hypotension—Betamethasone—ulcerative colitis	6.75e-05	0.000195	CcSEcCtD
Alitretinoin—RXRA—Adipogenesis—TNF—ulcerative colitis	6.73e-05	0.000331	CbGpPWpGaD
Alitretinoin—Urticaria—Hydrocortisone—ulcerative colitis	6.72e-05	0.000194	CcSEcCtD
Alitretinoin—Abdominal pain—Hydrocortisone—ulcerative colitis	6.68e-05	0.000193	CcSEcCtD
Alitretinoin—Body temperature increased—Hydrocortisone—ulcerative colitis	6.68e-05	0.000193	CcSEcCtD
Alitretinoin—Convulsion—Prednisone—ulcerative colitis	6.68e-05	0.000193	CcSEcCtD
Alitretinoin—Hypertension—Prednisone—ulcerative colitis	6.66e-05	0.000193	CcSEcCtD
Alitretinoin—RXRA—Generic Transcription Pathway—VDR—ulcerative colitis	6.64e-05	0.000327	CbGpPWpGaD
Alitretinoin—CYP1A2—Biological oxidations—PTGS1—ulcerative colitis	6.63e-05	0.000326	CbGpPWpGaD
Alitretinoin—Musculoskeletal discomfort—Betamethasone—ulcerative colitis	6.58e-05	0.00019	CcSEcCtD
Alitretinoin—Musculoskeletal discomfort—Dexamethasone—ulcerative colitis	6.58e-05	0.00019	CcSEcCtD
Alitretinoin—RXRA—NRF2 pathway—TGFB1—ulcerative colitis	6.57e-05	0.000323	CbGpPWpGaD
Alitretinoin—Myalgia—Prednisone—ulcerative colitis	6.56e-05	0.00019	CcSEcCtD
Alitretinoin—Arthralgia—Prednisone—ulcerative colitis	6.56e-05	0.00019	CcSEcCtD
Alitretinoin—Feeling abnormal—Triamcinolone—ulcerative colitis	6.56e-05	0.00019	CcSEcCtD
Alitretinoin—Feeling abnormal—Methylprednisolone—ulcerative colitis	6.55e-05	0.000189	CcSEcCtD
Alitretinoin—Anxiety—Prednisone—ulcerative colitis	6.54e-05	0.000189	CcSEcCtD
Alitretinoin—Insomnia—Betamethasone—ulcerative colitis	6.53e-05	0.000189	CcSEcCtD
Alitretinoin—Insomnia—Dexamethasone—ulcerative colitis	6.53e-05	0.000189	CcSEcCtD
Alitretinoin—RXRG—Gene Expression—VDR—ulcerative colitis	6.52e-05	0.000321	CbGpPWpGaD
Alitretinoin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ulcerative colitis	6.52e-05	0.000189	CcSEcCtD
Alitretinoin—Gastrointestinal pain—Methylprednisolone—ulcerative colitis	6.5e-05	0.000188	CcSEcCtD
Alitretinoin—Paraesthesia—Betamethasone—ulcerative colitis	6.49e-05	0.000188	CcSEcCtD
Alitretinoin—Paraesthesia—Dexamethasone—ulcerative colitis	6.49e-05	0.000188	CcSEcCtD
Alitretinoin—Discomfort—Prednisone—ulcerative colitis	6.48e-05	0.000188	CcSEcCtD
Alitretinoin—RARB—Gene Expression—VDR—ulcerative colitis	6.39e-05	0.000315	CbGpPWpGaD
Alitretinoin—Hypersensitivity—Prednisolone—ulcerative colitis	6.38e-05	0.000185	CcSEcCtD
Alitretinoin—Dyspepsia—Betamethasone—ulcerative colitis	6.36e-05	0.000184	CcSEcCtD
Alitretinoin—Dyspepsia—Dexamethasone—ulcerative colitis	6.36e-05	0.000184	CcSEcCtD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—NFKB1—ulcerative colitis	6.36e-05	0.000313	CbGpPWpGaD
Alitretinoin—CYP1A2—Aryl Hydrocarbon Receptor—NFKB1—ulcerative colitis	6.34e-05	0.000312	CbGpPWpGaD
Alitretinoin—Urticaria—Triamcinolone—ulcerative colitis	6.33e-05	0.000183	CcSEcCtD
Alitretinoin—Urticaria—Methylprednisolone—ulcerative colitis	6.31e-05	0.000183	CcSEcCtD
Alitretinoin—Body temperature increased—Triamcinolone—ulcerative colitis	6.29e-05	0.000182	CcSEcCtD
Alitretinoin—Oedema—Prednisone—ulcerative colitis	6.29e-05	0.000182	CcSEcCtD
Alitretinoin—Anaphylactic shock—Prednisone—ulcerative colitis	6.29e-05	0.000182	CcSEcCtD
Alitretinoin—Abdominal pain—Methylprednisolone—ulcerative colitis	6.28e-05	0.000182	CcSEcCtD
Alitretinoin—Decreased appetite—Dexamethasone—ulcerative colitis	6.28e-05	0.000182	CcSEcCtD
Alitretinoin—Decreased appetite—Betamethasone—ulcerative colitis	6.28e-05	0.000182	CcSEcCtD
Alitretinoin—Infection—Prednisone—ulcerative colitis	6.25e-05	0.000181	CcSEcCtD
Alitretinoin—Gastrointestinal disorder—Dexamethasone—ulcerative colitis	6.24e-05	0.00018	CcSEcCtD
Alitretinoin—Gastrointestinal disorder—Betamethasone—ulcerative colitis	6.24e-05	0.00018	CcSEcCtD
Alitretinoin—Hypersensitivity—Hydrocortisone—ulcerative colitis	6.23e-05	0.00018	CcSEcCtD
Alitretinoin—Fatigue—Betamethasone—ulcerative colitis	6.23e-05	0.00018	CcSEcCtD
Alitretinoin—Fatigue—Dexamethasone—ulcerative colitis	6.23e-05	0.00018	CcSEcCtD
Alitretinoin—Shock—Prednisone—ulcerative colitis	6.19e-05	0.000179	CcSEcCtD
Alitretinoin—ABCB1—Allograft Rejection—IFNG—ulcerative colitis	6.19e-05	0.000305	CbGpPWpGaD
Alitretinoin—Pain—Dexamethasone—ulcerative colitis	6.18e-05	0.000179	CcSEcCtD
Alitretinoin—Pain—Betamethasone—ulcerative colitis	6.18e-05	0.000179	CcSEcCtD
Alitretinoin—Nervous system disorder—Prednisone—ulcerative colitis	6.17e-05	0.000179	CcSEcCtD
Alitretinoin—Tachycardia—Prednisone—ulcerative colitis	6.14e-05	0.000178	CcSEcCtD
Alitretinoin—RXRB—Gene Expression—VDR—ulcerative colitis	6.13e-05	0.000302	CbGpPWpGaD
Alitretinoin—RARA—Gene Expression—VDR—ulcerative colitis	6.13e-05	0.000302	CbGpPWpGaD
Alitretinoin—Skin disorder—Prednisone—ulcerative colitis	6.11e-05	0.000177	CcSEcCtD
Alitretinoin—Hyperhidrosis—Prednisone—ulcerative colitis	6.08e-05	0.000176	CcSEcCtD
Alitretinoin—Asthenia—Hydrocortisone—ulcerative colitis	6.07e-05	0.000176	CcSEcCtD
Alitretinoin—Anorexia—Prednisone—ulcerative colitis	6e-05	0.000174	CcSEcCtD
Alitretinoin—Pruritus—Hydrocortisone—ulcerative colitis	5.98e-05	0.000173	CcSEcCtD
Alitretinoin—Feeling abnormal—Betamethasone—ulcerative colitis	5.95e-05	0.000172	CcSEcCtD
Alitretinoin—Feeling abnormal—Dexamethasone—ulcerative colitis	5.95e-05	0.000172	CcSEcCtD
Alitretinoin—ABCB1—Transmembrane transport of small molecules—SLC22A5—ulcerative colitis	5.93e-05	0.000292	CbGpPWpGaD
Alitretinoin—ABCB1—Transmembrane transport of small molecules—SLC22A4—ulcerative colitis	5.93e-05	0.000292	CbGpPWpGaD
Alitretinoin—Gastrointestinal pain—Betamethasone—ulcerative colitis	5.91e-05	0.000171	CcSEcCtD
Alitretinoin—Gastrointestinal pain—Dexamethasone—ulcerative colitis	5.91e-05	0.000171	CcSEcCtD
Alitretinoin—Hypersensitivity—Triamcinolone—ulcerative colitis	5.87e-05	0.00017	CcSEcCtD
Alitretinoin—Hypersensitivity—Methylprednisolone—ulcerative colitis	5.85e-05	0.000169	CcSEcCtD
Alitretinoin—Diarrhoea—Hydrocortisone—ulcerative colitis	5.79e-05	0.000167	CcSEcCtD
Alitretinoin—ABCB1—Allograft Rejection—CXCL8—ulcerative colitis	5.75e-05	0.000283	CbGpPWpGaD
Alitretinoin—Urticaria—Betamethasone—ulcerative colitis	5.74e-05	0.000166	CcSEcCtD
Alitretinoin—Urticaria—Dexamethasone—ulcerative colitis	5.74e-05	0.000166	CcSEcCtD
Alitretinoin—Musculoskeletal discomfort—Prednisone—ulcerative colitis	5.73e-05	0.000166	CcSEcCtD
Alitretinoin—Dizziness—Prednisolone—ulcerative colitis	5.73e-05	0.000166	CcSEcCtD
Alitretinoin—CRABP1—Metabolism—PPARG—ulcerative colitis	5.72e-05	0.000282	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism—PPARG—ulcerative colitis	5.72e-05	0.000282	CbGpPWpGaD
Alitretinoin—Asthenia—Triamcinolone—ulcerative colitis	5.71e-05	0.000165	CcSEcCtD
Alitretinoin—Body temperature increased—Betamethasone—ulcerative colitis	5.71e-05	0.000165	CcSEcCtD
Alitretinoin—Abdominal pain—Betamethasone—ulcerative colitis	5.71e-05	0.000165	CcSEcCtD
Alitretinoin—Body temperature increased—Dexamethasone—ulcerative colitis	5.71e-05	0.000165	CcSEcCtD
Alitretinoin—Abdominal pain—Dexamethasone—ulcerative colitis	5.71e-05	0.000165	CcSEcCtD
Alitretinoin—Asthenia—Methylprednisolone—ulcerative colitis	5.7e-05	0.000165	CcSEcCtD
Alitretinoin—Insomnia—Prednisone—ulcerative colitis	5.69e-05	0.000165	CcSEcCtD
Alitretinoin—Paraesthesia—Prednisone—ulcerative colitis	5.65e-05	0.000163	CcSEcCtD
Alitretinoin—Pruritus—Triamcinolone—ulcerative colitis	5.63e-05	0.000163	CcSEcCtD
Alitretinoin—Pruritus—Methylprednisolone—ulcerative colitis	5.62e-05	0.000163	CcSEcCtD
Alitretinoin—Dizziness—Hydrocortisone—ulcerative colitis	5.59e-05	0.000162	CcSEcCtD
Alitretinoin—Dyspepsia—Prednisone—ulcerative colitis	5.54e-05	0.00016	CcSEcCtD
Alitretinoin—ABCB1—Allograft Rejection—IL1B—ulcerative colitis	5.52e-05	0.000272	CbGpPWpGaD
Alitretinoin—ABCB1—Allograft Rejection—IL2—ulcerative colitis	5.5e-05	0.000271	CbGpPWpGaD
Alitretinoin—Decreased appetite—Prednisone—ulcerative colitis	5.47e-05	0.000158	CcSEcCtD
Alitretinoin—Rash—Prednisolone—ulcerative colitis	5.46e-05	0.000158	CcSEcCtD
Alitretinoin—Dermatitis—Prednisolone—ulcerative colitis	5.45e-05	0.000158	CcSEcCtD
Alitretinoin—Diarrhoea—Methylprednisolone—ulcerative colitis	5.44e-05	0.000157	CcSEcCtD
Alitretinoin—RXRA—Adipogenesis—IL6—ulcerative colitis	5.43e-05	0.000267	CbGpPWpGaD
Alitretinoin—Fatigue—Prednisone—ulcerative colitis	5.42e-05	0.000157	CcSEcCtD
Alitretinoin—Headache—Prednisolone—ulcerative colitis	5.42e-05	0.000157	CcSEcCtD
Alitretinoin—Constipation—Prednisone—ulcerative colitis	5.38e-05	0.000156	CcSEcCtD
Alitretinoin—Vomiting—Hydrocortisone—ulcerative colitis	5.38e-05	0.000156	CcSEcCtD
Alitretinoin—Rash—Hydrocortisone—ulcerative colitis	5.33e-05	0.000154	CcSEcCtD
Alitretinoin—Dermatitis—Hydrocortisone—ulcerative colitis	5.33e-05	0.000154	CcSEcCtD
Alitretinoin—RXRA—Transmembrane transport of small molecules—ABCB1—ulcerative colitis	5.31e-05	0.000262	CbGpPWpGaD
Alitretinoin—Headache—Hydrocortisone—ulcerative colitis	5.3e-05	0.000153	CcSEcCtD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—TGFB1—ulcerative colitis	5.3e-05	0.000261	CbGpPWpGaD
Alitretinoin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—ulcerative colitis	5.28e-05	0.00026	CbGpPWpGaD
Alitretinoin—Dizziness—Triamcinolone—ulcerative colitis	5.27e-05	0.000152	CcSEcCtD
Alitretinoin—Dizziness—Methylprednisolone—ulcerative colitis	5.25e-05	0.000152	CcSEcCtD
Alitretinoin—Feeling abnormal—Prednisone—ulcerative colitis	5.18e-05	0.00015	CcSEcCtD
Alitretinoin—Asthenia—Dexamethasone—ulcerative colitis	5.18e-05	0.00015	CcSEcCtD
Alitretinoin—Asthenia—Betamethasone—ulcerative colitis	5.18e-05	0.00015	CcSEcCtD
Alitretinoin—Gastrointestinal pain—Prednisone—ulcerative colitis	5.14e-05	0.000149	CcSEcCtD
Alitretinoin—CRABP1—Metabolism—ALB—ulcerative colitis	5.14e-05	0.000253	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism—ALB—ulcerative colitis	5.14e-05	0.000253	CbGpPWpGaD
Alitretinoin—Nausea—Prednisolone—ulcerative colitis	5.14e-05	0.000149	CcSEcCtD
Alitretinoin—RXRA—Gene Expression—HNF4A—ulcerative colitis	5.13e-05	0.000253	CbGpPWpGaD
Alitretinoin—Pruritus—Betamethasone—ulcerative colitis	5.11e-05	0.000148	CcSEcCtD
Alitretinoin—Pruritus—Dexamethasone—ulcerative colitis	5.11e-05	0.000148	CcSEcCtD
Alitretinoin—Vomiting—Triamcinolone—ulcerative colitis	5.06e-05	0.000146	CcSEcCtD
Alitretinoin—Vomiting—Methylprednisolone—ulcerative colitis	5.05e-05	0.000146	CcSEcCtD
Alitretinoin—Nausea—Hydrocortisone—ulcerative colitis	5.02e-05	0.000145	CcSEcCtD
Alitretinoin—Rash—Triamcinolone—ulcerative colitis	5.02e-05	0.000145	CcSEcCtD
Alitretinoin—Dermatitis—Triamcinolone—ulcerative colitis	5.02e-05	0.000145	CcSEcCtD
Alitretinoin—Rash—Methylprednisolone—ulcerative colitis	5.01e-05	0.000145	CcSEcCtD
Alitretinoin—Dermatitis—Methylprednisolone—ulcerative colitis	5e-05	0.000145	CcSEcCtD
Alitretinoin—RXRA—Gene Expression—MAML2—ulcerative colitis	5e-05	0.000246	CbGpPWpGaD
Alitretinoin—Urticaria—Prednisone—ulcerative colitis	5e-05	0.000145	CcSEcCtD
Alitretinoin—Headache—Triamcinolone—ulcerative colitis	4.99e-05	0.000144	CcSEcCtD
Alitretinoin—Headache—Methylprednisolone—ulcerative colitis	4.98e-05	0.000144	CcSEcCtD
Alitretinoin—Body temperature increased—Prednisone—ulcerative colitis	4.97e-05	0.000144	CcSEcCtD
Alitretinoin—Abdominal pain—Prednisone—ulcerative colitis	4.97e-05	0.000144	CcSEcCtD
Alitretinoin—RARG—Gene Expression—PPARG—ulcerative colitis	4.97e-05	0.000245	CbGpPWpGaD
Alitretinoin—RXRA—Transmembrane transport of small molecules—ADCY5—ulcerative colitis	4.96e-05	0.000244	CbGpPWpGaD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—TNF—ulcerative colitis	4.95e-05	0.000243	CbGpPWpGaD
Alitretinoin—Diarrhoea—Betamethasone—ulcerative colitis	4.94e-05	0.000143	CcSEcCtD
Alitretinoin—Diarrhoea—Dexamethasone—ulcerative colitis	4.94e-05	0.000143	CcSEcCtD
Alitretinoin—CYP1A2—Aryl Hydrocarbon Receptor—TNF—ulcerative colitis	4.93e-05	0.000243	CbGpPWpGaD
Alitretinoin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—ulcerative colitis	4.93e-05	0.000243	CbGpPWpGaD
Alitretinoin—Dizziness—Betamethasone—ulcerative colitis	4.78e-05	0.000138	CcSEcCtD
Alitretinoin—Dizziness—Dexamethasone—ulcerative colitis	4.78e-05	0.000138	CcSEcCtD
Alitretinoin—Nausea—Triamcinolone—ulcerative colitis	4.73e-05	0.000137	CcSEcCtD
Alitretinoin—Nausea—Methylprednisolone—ulcerative colitis	4.72e-05	0.000137	CcSEcCtD
Alitretinoin—Hypersensitivity—Prednisone—ulcerative colitis	4.64e-05	0.000134	CcSEcCtD
Alitretinoin—RXRA—Generic Transcription Pathway—PPARG—ulcerative colitis	4.63e-05	0.000228	CbGpPWpGaD
Alitretinoin—Vomiting—Betamethasone—ulcerative colitis	4.59e-05	0.000133	CcSEcCtD
Alitretinoin—Vomiting—Dexamethasone—ulcerative colitis	4.59e-05	0.000133	CcSEcCtD
Alitretinoin—Rash—Dexamethasone—ulcerative colitis	4.56e-05	0.000132	CcSEcCtD
Alitretinoin—Rash—Betamethasone—ulcerative colitis	4.56e-05	0.000132	CcSEcCtD
Alitretinoin—Dermatitis—Dexamethasone—ulcerative colitis	4.55e-05	0.000132	CcSEcCtD
Alitretinoin—Dermatitis—Betamethasone—ulcerative colitis	4.55e-05	0.000132	CcSEcCtD
Alitretinoin—RXRG—Gene Expression—PPARG—ulcerative colitis	4.55e-05	0.000224	CbGpPWpGaD
Alitretinoin—Headache—Dexamethasone—ulcerative colitis	4.53e-05	0.000131	CcSEcCtD
Alitretinoin—Headache—Betamethasone—ulcerative colitis	4.53e-05	0.000131	CcSEcCtD
Alitretinoin—Asthenia—Prednisone—ulcerative colitis	4.51e-05	0.000131	CcSEcCtD
Alitretinoin—CRABP2—Metabolism—PTGS2—ulcerative colitis	4.5e-05	0.000222	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—PTGS2—ulcerative colitis	4.5e-05	0.000222	CbGpPWpGaD
Alitretinoin—RARB—Gene Expression—PPARG—ulcerative colitis	4.46e-05	0.000219	CbGpPWpGaD
Alitretinoin—Pruritus—Prednisone—ulcerative colitis	4.45e-05	0.000129	CcSEcCtD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—TP53—ulcerative colitis	4.36e-05	0.000215	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—PPARG—ulcerative colitis	4.35e-05	0.000214	CbGpPWpGaD
Alitretinoin—Diarrhoea—Prednisone—ulcerative colitis	4.3e-05	0.000125	CcSEcCtD
Alitretinoin—Nausea—Betamethasone—ulcerative colitis	4.29e-05	0.000124	CcSEcCtD
Alitretinoin—Nausea—Dexamethasone—ulcerative colitis	4.29e-05	0.000124	CcSEcCtD
Alitretinoin—ABCB1—Allograft Rejection—TGFB1—ulcerative colitis	4.29e-05	0.000211	CbGpPWpGaD
Alitretinoin—RARA—Gene Expression—PPARG—ulcerative colitis	4.27e-05	0.00021	CbGpPWpGaD
Alitretinoin—RXRB—Gene Expression—PPARG—ulcerative colitis	4.27e-05	0.00021	CbGpPWpGaD
Alitretinoin—Dizziness—Prednisone—ulcerative colitis	4.16e-05	0.00012	CcSEcCtD
Alitretinoin—ABCB1—Allograft Rejection—TNF—ulcerative colitis	4.01e-05	0.000197	CbGpPWpGaD
Alitretinoin—Vomiting—Prednisone—ulcerative colitis	4e-05	0.000116	CcSEcCtD
Alitretinoin—Rash—Prednisone—ulcerative colitis	3.97e-05	0.000115	CcSEcCtD
Alitretinoin—Dermatitis—Prednisone—ulcerative colitis	3.96e-05	0.000115	CcSEcCtD
Alitretinoin—Headache—Prednisone—ulcerative colitis	3.94e-05	0.000114	CcSEcCtD
Alitretinoin—RXRA—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	3.89e-05	0.000191	CbGpPWpGaD
Alitretinoin—Nausea—Prednisone—ulcerative colitis	3.74e-05	0.000108	CcSEcCtD
Alitretinoin—ABCB1—Transmembrane transport of small molecules—SLC11A1—ulcerative colitis	3.69e-05	0.000182	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—JAK2—ulcerative colitis	3.64e-05	0.000179	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—PTGS1—ulcerative colitis	3.56e-05	0.000175	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—RELA—ulcerative colitis	3.53e-05	0.000174	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	3.5e-05	0.000172	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—CHP1—ulcerative colitis	3.4e-05	0.000168	CbGpPWpGaD
Alitretinoin—RXRA—Transmembrane transport of small molecules—ALB—ulcerative colitis	3.32e-05	0.000164	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—CALM3—ulcerative colitis	3.2e-05	0.000158	CbGpPWpGaD
Alitretinoin—RXRA—Gene Expression—VDR—ulcerative colitis	3.19e-05	0.000157	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	3.06e-05	0.000151	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—MMP9—ulcerative colitis	3e-05	0.000148	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—NFKB1—ulcerative colitis	2.97e-05	0.000146	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—DLD—ulcerative colitis	2.94e-05	0.000145	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—ulcerative colitis	2.93e-05	0.000144	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—CHP1—ulcerative colitis	2.72e-05	0.000134	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—STAT3—ulcerative colitis	2.67e-05	0.000132	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—ulcerative colitis	2.55e-05	0.000125	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—ulcerative colitis	2.54e-05	0.000125	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—ABCB1—ulcerative colitis	2.49e-05	0.000123	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—TGFB1—ulcerative colitis	2.48e-05	0.000122	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—DLD—ulcerative colitis	2.35e-05	0.000115	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—ADCY5—ulcerative colitis	2.32e-05	0.000114	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—TNF—ulcerative colitis	2.31e-05	0.000114	CbGpPWpGaD
Alitretinoin—RXRA—Gene Expression—PPARG—ulcerative colitis	2.23e-05	0.00011	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—ulcerative colitis	2.12e-05	0.000104	CbGpPWpGaD
Alitretinoin—ABCB1—Transmembrane transport of small molecules—ADCY5—ulcerative colitis	1.98e-05	9.75e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—ulcerative colitis	1.98e-05	9.73e-05	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—IL6—ulcerative colitis	1.87e-05	9.19e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—ulcerative colitis	1.74e-05	8.58e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—PPARG—ulcerative colitis	1.73e-05	8.53e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—ALB—ulcerative colitis	1.56e-05	7.67e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—PTGS1—ulcerative colitis	1.42e-05	6.99e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—PTGS2—ulcerative colitis	1.36e-05	6.71e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Transmembrane transport of small molecules—ALB—ulcerative colitis	1.33e-05	6.54e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—CALM3—ulcerative colitis	1.28e-05	6.3e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	1.24e-05	6.11e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—PTGS1—ulcerative colitis	1.13e-05	5.58e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	1.12e-05	5.49e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—CALM3—ulcerative colitis	1.02e-05	5.03e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	9.76e-06	4.8e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—ADCY5—ulcerative colitis	9.28e-06	4.57e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—ABCB1—ulcerative colitis	7.94e-06	3.91e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—ADCY5—ulcerative colitis	7.41e-06	3.65e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—PPARG—ulcerative colitis	6.92e-06	3.41e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—ALB—ulcerative colitis	6.22e-06	3.06e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—PPARG—ulcerative colitis	5.53e-06	2.72e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—PTGS2—ulcerative colitis	5.44e-06	2.68e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—ALB—ulcerative colitis	4.97e-06	2.45e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—PTGS2—ulcerative colitis	4.35e-06	2.14e-05	CbGpPWpGaD
